首页 | 本学科首页   官方微博 | 高级检索  
     


Endothelial function is impaired in patients with primary antiphospholipid syndrome
Authors:Stalc Monika  Poredos Pavel  Peternel Polona  Tomsic Matija  Sebestjen Miran  Kveder Tanja
Affiliation:Department of Vascular Disease, Zaloska c7, Clinical Centre, SI-1000 Ljubljana, Slovenia. monikastalc@email.si
Abstract:INTRODUCTION: The aim of this study was to evaluate endothelial function in patients with primary antiphospholipid syndrome (PAPS). PATIENTS AND METHODS: Flow mediated (FMD) and glyceryl trinitrate (GTN) induced dilation of the right brachial artery were studied in 25 patients with PAPS and 25 controls matched by age, sex and conventional risk factors for atherosclerosis. Fibrinogen, D-dimer, adhesion molecules, tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) antigens and activities were measured. RESULTS: Mean (SD) FMD was significantly lower in PAPS than in controls (8+/-5% vs. 15+/-6%, P<0.001); GTN-induced dilation did not differ between the groups. There was a correlation between the baseline diameter of the brachial artery and duration of the disease (-0.56, P<0.05) and between GTN induced dilation and duration of the disease (0.51, P<0.05). Concentrations of vascular cell adhesion molecule-1 (P<0.001), intracellular adhesion molecule-1 (P<0.001) and fibrinogen (P<0.05) were higher in patients than in controls but no differences were observed for D-dimer, t-PA and PAI-1 antigens and activities. There was correlation between concentration of vascular cell adhesion molecule-1 and FMD (-0.35, P<0.05) and between intracellular adhesion molecule-1 and FMD (-0.41, P<0.05). CONCLUSIONS: This study shows that endothelial function is impaired in patients with primary APS, possibly contributing to accelerated atherosclerosis and thromboembolic complications in these patients.
Keywords:APS, antiphospholipid syndrome   aPL, antiphospholipid antibodies   aCL, anticardiolipin antibodies   LA, lupus anticoagulant antibodies   EC, endothelial cell   β2GPI, beta2 glycoprotein I   FMD, flow mediated vasodilation   sVCAM-1, soluble vascular cell adhesion molecule-1   sICAM-1, soluble intracellular adhesion molecule-1   t-PA, tissue plasminogen activator   PAI-1, plasminogen activator inhibitor-1   vWF, von Willebrand factor   TF, tissue factor   HDL, high density lipoprotein   LDL, low density lipoprotein   ELISA, enzyme-linked immunosorbent assay   ACE, angiotensin-converting enzyme   GTN, glyceryl trinitrate
本文献已被 ScienceDirect PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号